Related Experiment Video

Updated: Jul 3, 2026

Measuring Psoriasis Severity at Home
02:28

Measuring Psoriasis Severity at Home

Published on: March 1, 2024

Development and validation of a preliminary definition of minimal disease activity in patients with juvenile

Silvia Magni-Manzoni1, Nicolino Ruperto, Angela Pistorio

  • 1Fondazione Istituto di Ricovero e Cura a Carattere Scientifico Policlinico S. Matteo, Pavia, Italy.

Arthritis and Rheumatism
|August 1, 2008
PubMed
Abstract

Insights

Researchers defined minimal disease activity (MDA) for juvenile idiopathic arthritis (JIA) patients. This new MDA definition provides a valuable treatment target for JIA clinical trials and studies.

Area of Science:

  • Pediatric Rheumatology
  • Clinical Trial Design
  • Disease Activity Measurement

Background:

  • Juvenile idiopathic arthritis (JIA) management requires objective measures of disease activity.
  • Defining minimal disease activity (MDA) is crucial for setting treatment targets in JIA.

Purpose of the Study:

  • To develop and validate a precise definition for minimal disease activity (MDA) in patients diagnosed with juvenile idiopathic arthritis (JIA).

Main Methods:

  • Retrospective chart review of JIA patients over 16 years to identify high disease activity and MDA states.
  • Utilized receiver operating characteristic (ROC) curve analysis to determine optimal cutoff values for JIA activity measures.
  • Employed multivariate analysis to establish MDA definitions for oligoarticular and polyarticular JIA, followed by discriminant and construct validity assessments.

Main Results:

  • Established MDA criteria for oligoarthritis: physician global assessment ≤2.5 cm and 0 swollen joints.
  • Defined MDA for polyarthritis: physician global assessment ≤3.4 cm, parent global assessment ≤2.1 cm, and ≤1 swollen joint.
  • Validated MDA definition demonstrated strong discriminant and construct validity in observational studies and controlled trials.

Conclusions:

  • A preliminary definition of MDA in JIA has been successfully developed.
  • This MDA definition serves as a practical treatment target for JIA patients.
  • Proposed inclusion of this MDA definition as a key outcome measure in future JIA research and clinical trials.

Related Concept Videos

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation01:21

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies01:27

Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies

Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
Inflammatory Bowel Disease IV: Clinical Manifestations01:20

Inflammatory Bowel Disease IV: Clinical Manifestations

Inflammatory bowel disease (IBD) encompasses two major chronic disorders—ulcerative colitis and Crohn’s disease—each characterized by relapsing episodes of gastrointestinal inflammation. Although they share certain clinical features, their patterns of involvement and manifestations differ in ways that aid diagnosis and guide management.Ulcerative ColitisUlcerative colitis is limited to the colon and rectum and involves continuous inflammation of the mucosal layer. The disease course is marked...